Event agenda

Tuesday, 17 September 2024

13:30 - 14:00

14:00 - 14:05

14:35 - 14:50

Cationic polymers as non-viral vectors - Richard Hoogenboom, University of Ghent

Format:In-person

The development of next generation cationic polymers as non-viral gene delivery vectors will be discussed, going beyond L-PEI.

1 speaker

14:50 - 15:05

A COVID-19 mucosal vaccine formulation adjuvanted with Bacillus subtilis spores - University of Hasselt

Format:In-person

The SARS-CoV-2 receptor-binding domain (RBD) coadministered with Bacillus subtilis spores through the nasal route induces robust humoral and cellular, both mucosal and systemic immune responses in mice.

1 speaker

15:05 - 15:20

Intradermal vaccination: our Belgian experience - Patrick Soentjens, Institute of Tropical Medicine (ITM)

Format:In-person

We will highlight our experiences with different intradermal vaccine schedules against rabies, tick borne encephalitis, mpox and covid-19.

15:20 - 15:35

Short talks Academia Q&A

Format:In-person

15:35 - 16:00

Coffee Break

Format:In-person

16:00 - 16:10

Skin vaccination: challenges and opportunities – Vanessa Vankerckhoven, IDEVAX

Format:In-person

Skin vaccination offers a promising avenue in vaccine delivery. The talk will provide insights into delivery methods, immune response, stability, scalability, and regulatory hurdles, as well as clinical data.

1 speaker

16:10 - 16:20

A reducible carbamate ionizable lipid library tailored towards intramuscular and systemic therapeutic applications – Bram Bogaert, ETHERNA

Format:In-person

In this presentation, we report on the development of a novel series of ionizable lipids based on a reducible biscarbamate linker that are suited for multiple prophylactic and therapeutic applications.

1 speaker

16:20 - 16:30

Routes of administration: perspectives from the veterinary field – Dieter Vancraeynest, ZOETIS

Format:In-person

The veterinary field is confronted with very diverse animal species and often needs to mass administer vaccines at low cost. This talk will cover various routes of administration – focusing on opportunities and challenges.

1 speaker

16:30 - 16:40

Plant-made edible vaccines: A new approach for oral immunization – Jeroen Hofenk, SWIFTPHARMA

Format:In-person

The edible vaccine is a new development that allows the introduction of desired genes into plants. They offer many advantages such as ease of manufacture, storage, cost- effectiveness, and better accessibility and acceptability by people globally.

16:40 - 17:00

17:00 - 18:00

Networking reception

Format:In-person

17:00 - 18:00

MeetingsIn-person

Meeting block

Location:
  • Reception

Meeting duration:10 minute time slots

15 results

Session formats

Meeting locations